Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery: A Randomized, Single-Blinded Study View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2015-2016

ABSTRACT

Primary research hypothesis: Patients who continue their chronic ACEI therapy up to and including the morning of a non-cardiac, non-vascular surgery will experience more intraoperative hypotension than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #1: Patients who continue their chronic ACEI up to and including the morning of a non-cardiac, non-vascular surgery will experience better postoperative control of hypertension than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #2: Patients who continue their chronic ACEI up to and including the morning of a non-cardiac, non-vascular surgery will experience less acute renal failure than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #3: In the subgroup of patients with a preoperative systolic blood pressure less than 110 mmHg, those who continue their chronic ACEI therapy up to and including the morning of a non-cardiac, non-vascular surgery will experience more intraoperative hypotension than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #4: In the subgroup of patients above the age of 64, those who continue their chronic ACEI therapy up to and including the morning of a non-cardiac, non-vascular surgery will experience more intraoperative hypotension than those who transiently hold their chronic ACEI preoperatively. Detailed Description The purpose of this study is to determine if transient discontinuation of angiotensin converting enzyme inhibitors (ACEIs) is necessary prior to non-cardiac, non-vascular surgery. ACEIs have been associated with intraoperative hypotension during vascular and cardiac surgeries. Patients presenting to the University of Nebraska Medical Center Pre-Anesthesia Screening (PAS) Clinic who are on chronic ACEI therapy will be eligible for enrollment. Subjects will be randomized to either omit or continue their ACEI preoperatively. The outcome of interest is intraoperative hypotension defined as a systolic blood pressure less than 80 mmHg. Blood pressure will be followed not only throughout surgery, but also during recovery and the remainder of hospitalization. Renal function will be assessed with creatinine measurements in the PAS clinic and on the first postoperative day. No follow-up is planned beyond discharge from the hospital. More... »

URL

https://clinicaltrials.gov/show/NCT01669434

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3048", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "Primary research hypothesis: Patients who continue their chronic ACEI therapy up to and including the morning of a non-cardiac, non-vascular surgery will experience more intraoperative hypotension than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #1: Patients who continue their chronic ACEI up to and including the morning of a non-cardiac, non-vascular surgery will experience better postoperative control of hypertension than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #2: Patients who continue their chronic ACEI up to and including the morning of a non-cardiac, non-vascular surgery will experience less acute renal failure than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #3: In the subgroup of patients with a preoperative systolic blood pressure less than 110 mmHg, those who continue their chronic ACEI therapy up to and including the morning of a non-cardiac, non-vascular surgery will experience more intraoperative hypotension than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #4: In the subgroup of patients above the age of 64, those who continue their chronic ACEI therapy up to and including the morning of a non-cardiac, non-vascular surgery will experience more intraoperative hypotension than those who transiently hold their chronic ACEI preoperatively.\n\nDetailed Description\nThe purpose of this study is to determine if transient discontinuation of angiotensin converting enzyme inhibitors (ACEIs) is necessary prior to non-cardiac, non-vascular surgery. ACEIs have been associated with intraoperative hypotension during vascular and cardiac surgeries. Patients presenting to the University of Nebraska Medical Center Pre-Anesthesia Screening (PAS) Clinic who are on chronic ACEI therapy will be eligible for enrollment. Subjects will be randomized to either omit or continue their ACEI preoperatively. The outcome of interest is intraoperative hypotension defined as a systolic blood pressure less than 80 mmHg. Blood pressure will be followed not only throughout surgery, but also during recovery and the remainder of hospitalization. Renal function will be assessed with creatinine measurements in the PAS clinic and on the first postoperative day. No follow-up is planned beyond discharge from the hospital.", 
    "endDate": "2016-12-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT01669434", 
    "keywords": [
      "angiotensin converting enzyme inhibitor", 
      "blinded study", 
      "research hypothesis", 
      "patient", 
      "therapy", 
      "vascular surgery", 
      "hypotension", 
      "ACEi", 
      "secondary research", 
      "control", 
      "hypertension", 
      "failure", 
      "subgroup", 
      "systolic blood pressure", 
      "mmHg", 
      "age", 
      "discontinuation", 
      "angiotensin enzyme", 
      "Patients presenting", 
      "anesthesia", 
      "enrollment", 
      "blood pressure", 
      "General Surgery", 
      "recovery", 
      "remainder", 
      "hospitalization", 
      "renal function", 
      "measurement", 
      "discharge", 
      "hospital"
    ], 
    "name": "Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery: A Randomized, Single-Blinded Study", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT01669434"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00013.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.410442.7", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.266813.8", 
        "type": "Organization"
      }
    ], 
    "startDate": "2015-06-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "https://doi.org/10.1053/j.jvca.2007.12.020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002178014"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/bja/83.5.715", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006113661"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2014.07.944", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007976975"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/01.ane.0000146521.68059.a1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009559193"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000542-199408000-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011221795"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.111.059527", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012000502"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehu282", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028828034"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jvs.2013.07.025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029109883"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000539-200101000-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033661937"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aln.0b013e3182a10e26", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038967132"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/cc5713", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042075619", 
          "https://doi.org/10.1186/cc5713"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/pgmj.65.763.273", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045028081"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/ane.0b013e318241f6af", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045641198"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/ane.0000000000000076", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051868231"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aln.0000000000000686", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060337683"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aln.0000000000000739", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060337736"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aln.0000000000000756", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060337753"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aln.0000000000001404", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060338396"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT01669434"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT01669434'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT01669434'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT01669434'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT01669434'


 

This table displays all metadata directly associated to this object as RDF triples.

106 TRIPLES      16 PREDICATES      64 URIs      39 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT01669434 schema:about anzsrc-for:3048
2 schema:description Primary research hypothesis: Patients who continue their chronic ACEI therapy up to and including the morning of a non-cardiac, non-vascular surgery will experience more intraoperative hypotension than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #1: Patients who continue their chronic ACEI up to and including the morning of a non-cardiac, non-vascular surgery will experience better postoperative control of hypertension than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #2: Patients who continue their chronic ACEI up to and including the morning of a non-cardiac, non-vascular surgery will experience less acute renal failure than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #3: In the subgroup of patients with a preoperative systolic blood pressure less than 110 mmHg, those who continue their chronic ACEI therapy up to and including the morning of a non-cardiac, non-vascular surgery will experience more intraoperative hypotension than those who transiently hold their chronic ACEI preoperatively. Secondary research hypothesis #4: In the subgroup of patients above the age of 64, those who continue their chronic ACEI therapy up to and including the morning of a non-cardiac, non-vascular surgery will experience more intraoperative hypotension than those who transiently hold their chronic ACEI preoperatively. Detailed Description The purpose of this study is to determine if transient discontinuation of angiotensin converting enzyme inhibitors (ACEIs) is necessary prior to non-cardiac, non-vascular surgery. ACEIs have been associated with intraoperative hypotension during vascular and cardiac surgeries. Patients presenting to the University of Nebraska Medical Center Pre-Anesthesia Screening (PAS) Clinic who are on chronic ACEI therapy will be eligible for enrollment. Subjects will be randomized to either omit or continue their ACEI preoperatively. The outcome of interest is intraoperative hypotension defined as a systolic blood pressure less than 80 mmHg. Blood pressure will be followed not only throughout surgery, but also during recovery and the remainder of hospitalization. Renal function will be assessed with creatinine measurements in the PAS clinic and on the first postoperative day. No follow-up is planned beyond discharge from the hospital.
3 schema:endDate 2016-12-01T00:00:00Z
4 schema:keywords ACEi
5 General Surgery
6 Patients presenting
7 age
8 anesthesia
9 angiotensin converting enzyme inhibitor
10 angiotensin enzyme
11 blinded study
12 blood pressure
13 control
14 discharge
15 discontinuation
16 enrollment
17 failure
18 hospital
19 hospitalization
20 hypertension
21 hypotension
22 measurement
23 mmHg
24 patient
25 recovery
26 remainder
27 renal function
28 research hypothesis
29 secondary research
30 subgroup
31 systolic blood pressure
32 therapy
33 vascular surgery
34 schema:name Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery: A Randomized, Single-Blinded Study
35 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT01669434
36 schema:sdDatePublished 2019-03-07T15:24
37 schema:sdLicense https://scigraph.springernature.com/explorer/license/
38 schema:sdPublisher N27d5deccd021421d8dc620eac6e5ddd3
39 schema:sponsor https://www.grid.ac/institutes/grid.266813.8
40 https://www.grid.ac/institutes/grid.410442.7
41 schema:startDate 2015-06-01T00:00:00Z
42 schema:subjectOf sg:pub.10.1186/cc5713
43 https://doi.org/10.1016/j.jacc.2014.07.944
44 https://doi.org/10.1016/j.jvs.2013.07.025
45 https://doi.org/10.1053/j.jvca.2007.12.020
46 https://doi.org/10.1093/bja/83.5.715
47 https://doi.org/10.1093/eurheartj/ehu282
48 https://doi.org/10.1097/00000539-200101000-00006
49 https://doi.org/10.1097/00000542-199408000-00006
50 https://doi.org/10.1097/aln.0000000000000686
51 https://doi.org/10.1097/aln.0000000000000739
52 https://doi.org/10.1097/aln.0000000000000756
53 https://doi.org/10.1097/aln.0000000000001404
54 https://doi.org/10.1097/aln.0b013e3182a10e26
55 https://doi.org/10.1136/pgmj.65.763.273
56 https://doi.org/10.1161/circulationaha.111.059527
57 https://doi.org/10.1213/01.ane.0000146521.68059.a1
58 https://doi.org/10.1213/ane.0000000000000076
59 https://doi.org/10.1213/ane.0b013e318241f6af
60 schema:url https://clinicaltrials.gov/show/NCT01669434
61 sgo:license sg:explorer/license/
62 sgo:sdDataset clinical_trials
63 rdf:type schema:MedicalStudy
64 N27d5deccd021421d8dc620eac6e5ddd3 schema:name Springer Nature - SN SciGraph project
65 rdf:type schema:Organization
66 anzsrc-for:3048 schema:inDefinedTermSet anzsrc-for:
67 rdf:type schema:DefinedTerm
68 sg:pub.10.1186/cc5713 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042075619
69 https://doi.org/10.1186/cc5713
70 rdf:type schema:CreativeWork
71 https://doi.org/10.1016/j.jacc.2014.07.944 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007976975
72 rdf:type schema:CreativeWork
73 https://doi.org/10.1016/j.jvs.2013.07.025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029109883
74 rdf:type schema:CreativeWork
75 https://doi.org/10.1053/j.jvca.2007.12.020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002178014
76 rdf:type schema:CreativeWork
77 https://doi.org/10.1093/bja/83.5.715 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006113661
78 rdf:type schema:CreativeWork
79 https://doi.org/10.1093/eurheartj/ehu282 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028828034
80 rdf:type schema:CreativeWork
81 https://doi.org/10.1097/00000539-200101000-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033661937
82 rdf:type schema:CreativeWork
83 https://doi.org/10.1097/00000542-199408000-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011221795
84 rdf:type schema:CreativeWork
85 https://doi.org/10.1097/aln.0000000000000686 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060337683
86 rdf:type schema:CreativeWork
87 https://doi.org/10.1097/aln.0000000000000739 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060337736
88 rdf:type schema:CreativeWork
89 https://doi.org/10.1097/aln.0000000000000756 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060337753
90 rdf:type schema:CreativeWork
91 https://doi.org/10.1097/aln.0000000000001404 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060338396
92 rdf:type schema:CreativeWork
93 https://doi.org/10.1097/aln.0b013e3182a10e26 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038967132
94 rdf:type schema:CreativeWork
95 https://doi.org/10.1136/pgmj.65.763.273 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045028081
96 rdf:type schema:CreativeWork
97 https://doi.org/10.1161/circulationaha.111.059527 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012000502
98 rdf:type schema:CreativeWork
99 https://doi.org/10.1213/01.ane.0000146521.68059.a1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009559193
100 rdf:type schema:CreativeWork
101 https://doi.org/10.1213/ane.0000000000000076 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051868231
102 rdf:type schema:CreativeWork
103 https://doi.org/10.1213/ane.0b013e318241f6af schema:sameAs https://app.dimensions.ai/details/publication/pub.1045641198
104 rdf:type schema:CreativeWork
105 https://www.grid.ac/institutes/grid.266813.8 schema:Organization
106 https://www.grid.ac/institutes/grid.410442.7 schema:Organization
 




Preview window. Press ESC to close (or click here)


...